Category Industry Updates

Merck KGaA and Versant Ventures Launch Saturnus Bio to Advance Rare Genetic Cardiomyopathy Treatments

Merck KGaA Teams With Saturnus Bio to Build Precision Cardiology Portfolio for Rare Genetic Cardiomyopathies Merck KGaA, Darmstadt, Germany has entered a strategic research-stage collaboration with Saturnus Bio, a biotechnology company founded by Versant Ventures, in a move aimed at…

Read MoreMerck KGaA and Versant Ventures Launch Saturnus Bio to Advance Rare Genetic Cardiomyopathy Treatments

101 Therapeutics Unveils Clinical Evidence for 101-PGC-005 and Calls for Urgent Review in Bundibugyo Ebola Disease

101 Therapeutics Publicly Releases Clinical and Scientific Data for Macrophage-Targeted Anti-Inflammatory Candidate as It Seeks Urgent Review for Bundibugyo Ebola Outbreak Use 101 Therapeutics Ltd. has publicly released a broad package of clinical and scientific evidence for its investigational therapy…

Read More101 Therapeutics Unveils Clinical Evidence for 101-PGC-005 and Calls for Urgent Review in Bundibugyo Ebola Disease

Latin Clinical Trial Center Joins PhaseWell Research to Strengthen Clinical Research Access in Puerto Rico

Latin Clinical Trial Center Becomes Part of PhaseWell Research, Expanding Research and Therapeutic Access PhaseWell Research, a rapidly growing multisite clinical research organization dedicated to expanding access to clinical trials across diverse communities, has announced a strategic partnership with Latin…

Read MoreLatin Clinical Trial Center Joins PhaseWell Research to Strengthen Clinical Research Access in Puerto Rico

Senopsys Celebrates 20 Years of Enhancing Medicine Palatability for Patients Worldwide

Senopsys Celebrates 20 Years of Advancing Patient-Friendly Medicines Through Sensory Science Senopsys, a company recognized for its expertise in sensory science and pharmaceutical palatability solutions, is marking its 20th anniversary of serving the global biopharmaceutical industry. Over the past two…

Read MoreSenopsys Celebrates 20 Years of Enhancing Medicine Palatability for Patients Worldwide

Element Biosciences Upsizes Series E to Accelerate Global Expansion in Genomics and Multiomics

Element Biosciences Raises Upsized Series E to Accelerate Global Expansion Across Genomic, Multiomic, and Clinical Research Solutions Ecosystem Element Biosciences has announced an upsized Series E financing round, anchored by a $175 million investment from long-standing strategic backer Samsung Electronics,…

Read MoreElement Biosciences Upsizes Series E to Accelerate Global Expansion in Genomics and Multiomics